Ahead of the crucial domestic event lined up tomorrow, Nifty today formed a small-bodied bearish candle with a longer lower shadow on the d...

In the Nifty50 index, 10 stocks were trading in the green, while 40 stocks were in the red.

The pan-European STOXX 600 skid 0.3% after positive trading updates and commodity prices helped spark a rebound in shares in its previous s...

Traders' body CAIT raised objections over Aditya Birla Fashion and Retail's plans to raise Rs 1,500 crore by issuing 7.8 per cent stake to ...

A significant part of these companies’ portfolios has been hit by poor demand.

The stock quoted a 52-week high of Rs 1744.0 and a 52-week low of Rs 1087.75.

The Horlicks brand buyout is the biggest for the company in its over 87-year history.

The stocks that touched their 52-week highs were GlaxoSmithKline Consumer Healthcare and Ruchi Soya Industries.

Sensex gained 479 points to 38,623 while Nifty added 170 points to close at 11,303.

Over half of the 43 analysts tracking the stock have a ‘buy’ recommendation on it, as per Bloomberg data.

Before closing 0.75 per cent up at Rs 801.90, shares of IT major Infosys scaled fresh record high of Rs 809.95 during the day.

Sales increased by 12.42 per cent YoY to Rs 9,357 crore in Q3FY19 over Rs 8,323 crore in Q3FY18.

The private sector lender gained 4 per cent for the week ended December 7.

GSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.

Stock price corrections have been quite painful this year, but scratch the surface and you realise it’s not that bad after all.

While the new drug pricing policy has been given shape by the GoM, the jury still seems to be out on what will be the exact impact on the p...

Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...